biotech finance

R&D
light at the end of the tunnel

Brighter times ahead for biotech in 2024?

The biotech industry experienced heady highs in early 2021, but has since suffered from a tight financial climate that has brought bankruptcies and widespread redundancies.

News
healthcare dealmaking increases

Healthcare hits 2-yr M&A high, bucking trend

According to data released by LSEG Deals Intelligence, the healthcare sector saw a 35% increase on last year’s deals, reaching $174.6 billion in the first half of 2023 – a